Clinical Trial

Mild Water-filtered Infrared-A Whole-body Hyperthermia in Patients With Post-COVID Syndrome (HyPoCo)

Study acronym: HyPoCo
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 11, 2025 (before its estimated May 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study examines the efficacy of mild water-filtered whole-body hyperthermia during outpatient treatment in patients with post-COVID syndrome. The aim is to evaluate whether there can be an improvement in fatigue and quality of life. The duration of the study extends over a treatment period of approximately 2 weeks with two treatment units per week and a follow-up period of 3 months after the outpatient treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-11.
Status change: Recruiting → Active, Not Recruiting 2025-04-10
Trial Details
NCT Number NCT06204458
Lead Sponsor Universität Duisburg-Essen
Collaborators: Bavarian State Ministry of Health and Care
Conditions Post-COVID Syndrome
Enrollment 60 participants
Start Date 2024-02-20
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-11